Fulcrum Capital LLC Buys 3,847 Shares of Zoetis Inc. $ZTS

Fulcrum Capital LLC grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 7.3% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 56,393 shares of the company’s stock after acquiring an additional 3,847 shares during the quarter. Zoetis comprises about 1.9% of Fulcrum Capital LLC’s portfolio, making the stock its 18th biggest holding. Fulcrum Capital LLC’s holdings in Zoetis were worth $8,794,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of ZTS. Nuveen LLC bought a new stake in shares of Zoetis during the 1st quarter valued at $616,375,000. Mackenzie Financial Corp increased its stake in shares of Zoetis by 4,158.3% in the 1st quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock valued at $300,481,000 after purchasing an additional 1,782,110 shares during the last quarter. Polen Capital Management LLC increased its stake in shares of Zoetis by 17.6% in the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after purchasing an additional 1,313,653 shares during the last quarter. Amundi increased its stake in shares of Zoetis by 30.8% in the 1st quarter. Amundi now owns 3,595,628 shares of the company’s stock valued at $575,691,000 after purchasing an additional 846,909 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd increased its stake in shares of Zoetis by 475.9% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 900,261 shares of the company’s stock valued at $148,228,000 after purchasing an additional 743,926 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ZTS shares. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Argus reiterated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Piper Sandler lifted their price target on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $196.71.

Zoetis Trading Down 1.6%

Shares of ZTS stock opened at $141.05 on Friday. The firm has a market capitalization of $62.51 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.30 and a beta of 0.90. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $196.55. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The stock’s fifty day simple moving average is $149.24 and its 200 day simple moving average is $154.46.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.